Skip to main content
logo
Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
633.71
+5.56 (0.89%)
At close: Aug 26, 2026, 4:00 PM EDT
634.06
+0.35 (0.06%)
After-hours: Aug 26, 2026, 7:56 PM EDT

Thermo Fisher Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Operating Revenue
46,33745,19844,55743,73643,21242,89842,87942,37042,34642,49242,85743,42143,52443,80744,91544,16742,82041,12339,21139,059
Other Revenue
-1-1-1-----------------
Revenue
46,33645,19744,55643,73643,21242,89842,87942,37042,34642,49242,85743,42143,52443,80744,91544,16742,82041,12339,21139,059
Revenue Growth (YoY)
7.23%5.36%3.91%3.22%2.04%0.95%0.05%-2.42%-2.71%-3.00%-4.58%-1.69%1.64%6.53%14.55%13.08%11.95%14.57%21.70%37.06%
Cost of Revenue
27,34426,69726,25425,63525,36425,12325,13025,05025,03625,25825,75726,03526,16626,11925,94424,55622,86021,23819,57319,107
Gross Profit
18,99218,50018,30218,10117,84817,77517,74917,32017,31017,23417,10017,38617,35817,68818,97119,61119,96019,88519,63819,952
Selling, General & Admin
8,7738,6018,5278,4708,4538,5028,6028,5208,4698,4348,4408,4648,6538,7818,9408,8548,6118,3177,8577,843
Research & Development
1,4021,3911,3971,4151,4151,4011,3901,3431,3161,3221,3371,4011,4331,4531,4711,4721,4721,4501,4061,390
Other Operating Expenses
202120303030301111----333316
Operating Expenses
10,19510,0139,9449,9159,8989,93310,0229,8649,7869,7579,7789,86510,08610,23410,41110,32910,0869,7709,2669,249
Operating Income
8,7978,4878,3588,1867,9507,8427,7277,4567,5247,4777,3227,5217,2727,4548,5609,2829,87410,11510,37210,703
Interest Expense
-1,467-1,470-1,419-1,371-1,380-1,330-1,390-1,463-1,461-1,434-1,375-1,254-1,077-895-726-625-576-553-536-500
Interest & Investment Income
9321,0239939621,0051,0021,0781,1601,1291,01287972054240027213374494344
Earnings From Equity Investments
-52-35-41237-79-42-76-79-11-59-88-143-178-172-142-73-23-4-7
Currency Exchange Gain (Loss)
526366227--16-16-37-58-2962881261024719-2216259
Other Non Operating Income (Expenses)
-74-96-89-41-29-105-1113335-17-27-60-35-22-1118-161-114
EBT Excluding Unusual Items
8,1887,9727,8687,7817,5607,4257,3627,0507,0897,0196,7436,9446,6556,8478,0018,6739,3079,5849,87610,185
Merger & Restructuring Charges
-294-240-201-115-118-85-1108-171-90-220-388-104-232-68-82-67-52-72-37
Gain (Loss) on Sale of Investments
-13-40-382091121-689-46-58-83-64-161-93-58-746633
Gain (Loss) on Sale of Assets
-----------141414------
Asset Writedown
-154-108-94-252-252-252-252-219-219-219-219-60-60-60-46-12-12-122-122-142
Legal Settlements
--------19-19-1-19---18------
Other Unusual Items
-141-196-267-315-179-111-26-5491-204--205-394-7-63-708-747-731-911-170
Pretax Income
7,5867,3887,2687,1197,0206,9886,9956,7606,7796,5146,2396,2476,0286,4807,6637,7788,4238,6058,8379,869
Income Tax Expense
5985225475444364716576405945192843243024487037339739941,1091,300
Earnings From Continuing Operations
6,9886,8666,7216,5756,5846,5176,3386,1206,1855,9955,9555,9235,7266,0326,9607,0457,4507,6117,7288,569
Net Income to Company
6,9886,8666,7216,5756,5846,5176,3386,1206,1855,9955,9555,9235,7266,0326,9607,0457,4507,6117,7288,569
Minority Interest in Earnings
-21-18-17-5--3-31535394018-5-8-10-13-11-8-3-4
Net Income
6,9676,8486,7046,5706,5846,5146,3356,1356,2206,0345,9955,9415,7216,0246,9507,0327,4397,6037,7258,565
Net Income to Common
6,9676,8486,7046,5706,5846,5146,3356,1356,2206,0345,9955,9415,7216,0246,9507,0327,4397,6037,7258,565
Net Income Growth (YoY)
5.82%5.13%5.83%7.09%5.85%7.95%5.67%3.26%8.72%0.17%-13.74%-15.52%-23.09%-20.77%-10.03%-17.90%-13.46%-4.05%21.18%75.55%
Shares Outstanding (Basic)
374376377379380381382383384385386388389391392393393394394395
Shares Outstanding (Diluted)
375377378379381382383384386387388389391392394396396397397398
Shares Change (YoY)
-1.44%-1.38%-1.31%-1.30%-1.30%-1.36%-1.29%-1.16%-1.41%-1.34%-1.52%-1.71%-1.14%-1.07%-0.76%-0.50%-0.63%-0.44%-0.50%-0.63%
EPS (Basic)
18.6318.2417.7817.3417.3317.1016.5816.0216.2015.6715.5315.3314.7115.4317.7317.9218.9319.3219.6121.71
EPS (Diluted)
18.5818.1917.7417.3217.3017.0616.5315.9516.1315.5915.4515.2614.6415.3417.6317.7918.7919.1919.4621.54
EPS Growth (YoY)
7.45%6.67%7.32%8.54%7.24%9.37%6.99%4.56%10.18%1.64%-12.37%-14.23%-22.09%-20.03%-9.40%-17.43%-12.99%-3.46%21.93%76.67%

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Free Cash Flow
7,3186,7486,2936,1116,1706,7247,2677,7757,9637,5606,9276,5465,8545,6206,9115,6006,3367,0016,7897,916
Free Cash Flow Per Share
19.5217.9216.6516.1116.2217.6118.9720.2320.6619.5417.8516.8414.9714.3317.5414.1616.0217.6617.1019.91
Dividend Per Share
1.8001.7601.7201.6801.6401.6001.5601.5201.4801.4401.4001.3501.3001.2501.2001.1601.1201.0801.0401.000
Dividend Growth (YoY)
9.76%10.00%10.26%10.53%10.81%11.11%11.43%12.59%13.85%15.20%16.67%16.38%16.07%15.74%15.38%16.00%16.67%17.39%18.18%17.65%
Gross Margin
40.99%40.93%41.08%41.39%41.30%41.44%41.39%40.88%40.88%40.56%39.90%40.04%39.88%40.38%42.24%44.40%46.61%48.35%50.08%51.08%
Operating Margin
18.98%18.78%18.76%18.72%18.40%18.28%18.02%17.60%17.77%17.60%17.09%17.32%16.71%17.02%19.06%21.02%23.06%24.60%26.45%27.40%
Profit Margin
15.04%15.15%15.05%15.02%15.24%15.19%14.77%14.48%14.69%14.20%13.99%13.68%13.14%13.75%15.47%15.92%17.37%18.49%19.70%21.93%
Free Cash Flow Margin
15.79%14.93%14.12%13.97%14.28%15.67%16.95%18.35%18.80%17.79%16.16%15.08%13.45%12.83%15.39%12.68%14.80%17.03%17.31%20.27%
EBITDA
11,73911,29611,13810,99010,83310,81910,83510,66110,83210,86010,72810,93610,67210,83511,94112,49812,88012,94512,96413,214
EBITDA Margin
25.34%24.99%25.00%25.13%25.07%25.22%25.27%25.16%25.58%25.56%25.03%25.19%24.52%24.73%26.59%28.30%30.08%31.48%33.06%33.83%
D&A For EBITDA
2,9422,8092,7802,8042,8832,9773,1083,2053,3083,3833,4063,4153,4003,3813,3813,2163,0062,8302,5922,511
EBIT
8,7978,4878,3588,1867,9507,8427,7277,4567,5247,4777,3227,5217,2727,4548,5609,2829,87410,11510,37210,703
EBIT Margin
18.98%18.78%18.76%18.72%18.40%18.28%18.02%17.60%17.77%17.60%17.09%17.32%16.71%17.02%19.06%21.02%23.06%24.60%26.45%27.40%
Effective Tax Rate
7.88%7.07%7.53%7.64%6.21%6.74%9.39%9.47%8.76%7.97%4.55%5.19%5.01%6.91%9.17%9.42%11.55%11.55%12.55%13.17%
Revenue as Reported
46,33645,19744,55643,73643,21242,89842,87942,37042,34642,49242,85743,42143,52443,80744,91544,16742,82041,12339,21139,059
SEC Filings: 10-K · 10-Q